BAYSTATE NOBLE HOSPITAL — History
CCN 220065 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$70M
Latest Revenue (FY2022)
+22.0%
Revenue CAGR (3yr)
-16.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $47M | $63M | $70M | +11.8% | +22.0% |
| Operating Expenses | $64M | $69M | $82M | +19.4% | +13.0% |
| Operating Margin | -36.1% | -9.3% | -16.8% | -80.5% | +0.0% |
| Net Income | $-17M | $-6M | $-12M | -101.8% | +0.0% |
| Licensed Beds | 82 | 70 | 70 | +0.0% | -7.6% |
| Total Patient Days | 11,288 | 14,055 | 14,590 | +3.8% | +13.7% |
| Medicare Day % | 36% | 31% | 34% | +10.3% | -2.0% |
| Medicaid Day % | 4% | 5% | 5% | -5.1% | +8.5% |
COVID Impact & Recovery
Resilience Score: 73/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +48.9% ($47M → $70M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+22.0%
This Hospital
+7.6%
State Avg
Latest Margin
-16.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $82M | -7.1% |
| FY2024 (proj) | $93M | 2.6% |
| FY2025 (proj) | $105M | 12.2% |